Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Wall Street
Price Targets
Price Targets Summary
Jiangsu Hengrui Pharmaceuticals Co Ltd
According to Wall Street analysts, the average 1-year price target for
Jiangsu Hengrui Pharmaceuticals Co Ltd
is 81.55 CNY
with a low forecast of 50.5 CNY and a high forecast of 129.15 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Jiangsu Hengrui Pharmaceuticals Co Ltd's stock price target?
Price Target
81.55
CNY
According to Wall Street analysts, the average 1-year price target for
Jiangsu Hengrui Pharmaceuticals Co Ltd
is 81.55 CNY
with a low forecast of 50.5 CNY and a high forecast of 129.15 CNY.
What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Revenue forecast?
Projected CAGR
18%
For the last 13 years the
compound annual growth rate for
Jiangsu Hengrui Pharmaceuticals Co Ltd's revenue is
15%.
The projected
CAGR
for the next 4 years is
18%.
What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Operating Income forecast?
Projected CAGR
32%
For the last 13 years the
compound annual growth rate for
Jiangsu Hengrui Pharmaceuticals Co Ltd's operating income is
16%.
The projected
CAGR
for the next 4 years is
32%.
What is Jiangsu Hengrui Pharmaceuticals Co Ltd's Net Income forecast?
Projected CAGR
21%
For the last 13 years the
compound annual growth rate for
Jiangsu Hengrui Pharmaceuticals Co Ltd's net income is
16%.
The projected
CAGR
for the next 3 years is
21%.
